Long Term Follow up on Functional Gastrointestinal Disorder (FGID)

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02689648

Acronym

LUFT

Enrollment

400

Registered

2016-02-24

Start date

2016-02-01

Completion date

2025-05-01

Last updated

2026-05-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Functional Gastrointestinal Disorder

Brief summary

Long term prognosis and risk factors in functional gastrointestinal disorder (FGID) is largely unknown. The investigators plan to retrospectively analyse a cohort of children who were referred to the Pediatric Clinic due to abdominal pain with the aims to learn more about symptoms and effects of investigations performed. Furthermore, the investigators plan to contact the cases for a follow up using a validated questionnaire and analyse the long term prognosis and risk factors for prolonged severe symptoms.

Detailed description

Long term prognosis and risk factors in functional gastrointestinal disorder (FGID) is largely unknown. The investigators plan to retrospectively analyse a cohort of children who during the years 2010-2015 were referred to the Pediatric Clinic of Umeå University Hospital due to abdominal pain. The aims are to explore and descriptively describe the symptoms and effects of investigations performed. Furthermore, the investigators plan to contact the cases five years after the first contact for a follow up using a validated questionnaire of the ROME-III-criteria and analyse the long term prognosis and risk factors for prolonged severe symptoms.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

3 Years to 18 Years

Healthy volunteers

Inclusion criteria

At time of first visit the children had: 1. At least 2 months of abdominal pain 2. Age 3-18 years 3. No organic gastrointestinal diseases 4. No neuromuscular disease

Design outcomes

Primary

Measure	Time frame	Description
Percentage (%) of patients that fulfill the ROME-III criteria for FGID	5 years after fist visit +/- 1 year	Measured by the validated ROME-III questionnaire

Secondary

Measure	Time frame
ICD 10-diagnosis following the primary investigation	12 months after first visit
Current ICD 10-diagnosis	5 years after fist visit +/- 1 year
Number (n) of visits for the primary investigations	0-12 months after first visit

Countries

Sweden

Contacts

PRINCIPAL_INVESTIGATORStaffan K Berglund

Umeå University

Outcome results